Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Follow the companies behind these drugs with free AI briefings, catalyst countdowns and dilution alerts.

Florbetaben F 18 · Neuraceq, BAY-94-9172

Small molecule · Acts on amyloid beta neuritic plaques · developed by Lantheus

Approved FDA, Mar 2014
LNTH Developer
2 Registered trials

What is Florbetaben F 18?

Florbetaben F 18 is a radioactive diagnostic agent used with positron emission tomography (PET) to estimate amyloid beta neuritic plaque density in the brain. It is studied for imaging of amyloid pathology in Alzheimer's disease and in the heart in cardiac amyloidosis.

Summary written with AI from the sources listed at the end of this page.

At a glance

Also known as
Neuraceq, BAY-94-9172, Neuraceq (florbetaben 18F), Florbetaben F18
Drug type
Small molecule
Targets
amyloid beta neuritic plaques (biomarker)
Mechanism
Acts on amyloid beta neuritic plaques
Therapy area
Neurology
Developer
Lantheus (LNTH)
FDA status
Approved as Neuraceq (March 19, 2014), NDA204677 · FDA label
UNII
TLA7312TOI

✅ FDA-approved uses

From the indications section of the FDA label (version of Jul 24, 2026). Read the full label for the exact wording, limitations and safety information.

🧪 Clinical trials

TrialPhaseConditionStatusSponsor
NCT02681172 Phase 4 Alzheimer's Disease (AD) Completed LNTH
NCT06790394 Phase 1 Cardiac Amyloidosis Completed LNTH

Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.

Conditions studied

Alzheimer's Disease (AD)Cardiac Amyloidosis

More from Lantheus

Sources

Updated Nov 15, 2026. Something wrong or missing? Report it on the LNTH page.

Follow LNTH, the company behind Florbetaben F 18

See LNTH's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.

LNTH catalysts and pipeline →
Data: FDA (Drugs@FDA, Purple Book, DailyMed), NIH (NCI Thesaurus, GSRS, RxNorm), ClinicalTrials.gov • Informational purposes only, not medical or investment advice. • All drugs A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.